The findings revealed an inhibitory effect of OMD on the inflammatory response through the interleukin-1 receptor 1 (IL1R1)/nuclear factor-κB (NF-κB) signaling pathway. The gene discussed is NFKB1; the disease is occult macular dystrophy.